A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Clinical trial NCT03486899 · COMPLETED

Trial details

NCT number: NCT03486899
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Fibrosis Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis

Start date: 2018-06-19
Primary completion: 2020-09-14
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.